Oyvind S. Bruland
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 05, 2026
A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [212Pb]Pb-FAPI-46.
Journal: EJNMMI radiopharmacy and chemistry
Published: January 26, 2026
Radiobiological investigations of a [212Pb]Pb-carbonic anhydrase IX-targeting small-molecule ligand in renal cell carcinoma and colorectal cancer models.
Journal: International journal of radiation biology
Published: January 02, 2026
Addressing and supporting the unmet needs of sarcoma survivors: a qualitative study.
Journal: International journal of qualitative studies on health and well-being
Published: December 11, 2025
A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 01, 2025
Experiences and Hopes Among Patients with Colorectal Carcinoma and Peritoneal Metastases Who Are Participating in an Early-Phase Clinical Trial.
Journal: Cancers
Published: November 25, 2025
First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: September 30, 2025
Rethinking the role of bisphosphonates after denosumab treatment in locally advanced or unresectable aneurysmal bone cysts: A meta-analysis.
Journal: World journal of orthopedics
Published: March 16, 2025
Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 18, 2025
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 11, 2024
Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal.
Journal: Journal of bone oncology
Published: February 26, 2024
Last Updated: 09/26/2026